Bristol Myers to Acquire Karuna, a Neuroscience Drugmaker, for $14 Billion - The New York Times
- Bristol Myers to Acquire Karuna, a Neuroscience Drugmaker, for $14 Billion The New York Times
- Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion CNBC
- KRTX Stock Soars And Breaks Out On Bristol Myers' $14 Billion Takeover Investor's Business Daily
- Rocket Lab, Coinbase, Bristol Myers-Karuna deal: Trending tickers Yahoo Finance
- Bristol Myers Squibb unwraps $14B deal for Karuna FierceBiotech